InvestorsHub Logo

sunspotter

02/10/21 10:38 AM

#345220 RE: centillion #345218

"Big Pharma was negligent when Polymedic was in bankruptcy court back when, allowing Leo to dark horse a bid and nab everything they owned, including the golden Brilaciden package! Go Leo!"

It remains to be seen if that was negligence or just smarts.

I suspect that even then Big Pharma had access to data that was not available to the pink sheet penny stock speculator who holds brilacidin to be the savior of mankind.

Nowadays that would be even more true - the complete data package would be available to any BP suitor, and it seems that what they have seen from the various previous clinical trial programs (all (aborted, it would seem) has scared them off.

BTW, it's brilacidin, not "Brilaciden".

Hugon

02/10/21 11:01 AM

#345229 RE: centillion #345218

There are countless stories of drugs thrown into the trash bins repurposed by big pharma into blockbuster drugs. A drug may fail in one indication, be chucked into the garbage, and then be brought to life by another company and turned into a billion dollar plus gem. Happens more than you think. The thing is Brilacidin wasn’t junk. It completed a phase 2B with solid results inferior to a blockbuster drug in absssi dapto (you have heard of it or taken it). The antibiotic market (then was trash) and now the world is changing. And ipix has expanded the drug into a platform that keeps working. No failed trials.